These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27605903)

  • 1. The role of serum vitamin D levels in vitiligo.
    Karagün E; Ergin C; Baysak S; Erden G; Aktaş H; Ekiz Ö
    Postepy Dermatol Alergol; 2016 Aug; 33(4):300-2. PubMed ID: 27605903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of vitamin D in melanogenesis with an emphasis on vitiligo.
    AlGhamdi K; Kumar A; Moussa N
    Indian J Dermatol Venereol Leprol; 2013; 79(6):750-8. PubMed ID: 24177606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum brain-derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case-control study.
    Dawoud NM; Rajab AZ; El-Hefnawy SM; El-Bayoumy AM; Salem AM; Seleit I
    J Cosmet Dermatol; 2023 Aug; 22(8):2343-2351. PubMed ID: 36999446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Serum Vitamin D Levels in Patients with Vitiligo in Jordan: A Case-Control Study.
    Alshiyab DM; Al-Qarqaz FA; Heis LH; Muhaidat JM; Eddin WS; Atwan AA
    Dermatol Res Pract; 2019; 2019():2048409. PubMed ID: 31687010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation.
    Birlea SA; Costin GE; Norris DA
    Curr Drug Targets; 2008 Apr; 9(4):345-59. PubMed ID: 18393827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum 25-hydroxyvitamin D levels in vitiligo patients with and without autoimmune diseases.
    Saleh HM; Abdel Fattah NS; Hamza HT
    Photodermatol Photoimmunol Photomed; 2013 Feb; 29(1):34-40. PubMed ID: 23281695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in alopecia areata.
    Aksu Cerman A; Sarikaya Solak S; Kivanc Altunay I
    Br J Dermatol; 2014 Jun; 170(6):1299-304. PubMed ID: 24655364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D Receptor Expression in Vitiligo.
    Doss RW; El-Rifaie AA; Gohary YM; Rashed LA
    Indian J Dermatol; 2015; 60(6):544-8. PubMed ID: 26677265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: A prospective study.
    Karagüzel G; Sakarya NP; Bahadır S; Yaman S; Ökten A
    Clin Nutr ESPEN; 2016 Oct; 15():28-31. PubMed ID: 28531780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
    Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
    J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship Between the Serum Level of Vitamin D and Vitiligo: A Controlled Study on 300 Subjects.
    Khurrum H; AlGhamdi KM
    J Cutan Med Surg; 2016; 20(2):139-45. PubMed ID: 26458407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D Deficiency in Patients With Vitiligo: A Cross-Sectional Study From Basrah, Iraq.
    Mahmmod Z; Ismael DK
    Cureus; 2021 Dec; 13(12):e20733. PubMed ID: 35111426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
    Eldesouky F; Ibrahim AM; Sharaf SM
    J Clin Aesthet Dermatol; 2020 Oct; 13(10):24-27. PubMed ID: 33584953
    [No Abstract]   [Full Text] [Related]  

  • 14. Comorbidities associated with vitiligo: a ten-year retrospective study.
    Sheth VM; Guo Y; Qureshi AA
    Dermatology; 2013; 227(4):311-5. PubMed ID: 24107643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of vitamin D levels in patients with vitiligo vulgaris.
    Ustun I; Seraslan G; Gokce C; Motor S; Can Y; Ugur Inan M; Yilmaz N
    Acta Dermatovenerol Croat; 2014; 22(2):110-3. PubMed ID: 25102796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis.
    Upala S; Sanguankeo A
    Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):181-90. PubMed ID: 27005676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of a possible therapeutic role of vitamin D in a cohort of adult Caucasian vitiligo patients.
    Colucci R; Conti R; Dragoni F; Cammi A; Cianferotti L; Brandi ML; Moretti S
    Int J Vitam Nutr Res; 2020 Jun; 90(3-4):200-204. PubMed ID: 31414974
    [No Abstract]   [Full Text] [Related]  

  • 18. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris.
    Silverberg JI; Silverberg AI; Malka E; Silverberg NB
    J Am Acad Dermatol; 2010 Jun; 62(6):937-41. PubMed ID: 20466170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Patients with Vitiligo More Prone to Myocardial Infarction?: A Case-control Study.
    Ahmed Abdel Rahman SH; Hussein MS; Mansour AI
    J Clin Aesthet Dermatol; 2019 Nov; 12(11):28-31. PubMed ID: 32038754
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the correlation between serum levels of vitamin D and vitamin D receptor gene polymorphisms in an Egyptian population.
    Sobeih S; Mashaly HM; Gawdat H; Amr K; Hamid MF; Shaalan E
    Int J Dermatol; 2016 Dec; 55(12):1329-1335. PubMed ID: 27420410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.